PRAC antibody (N-Term)
-
- Target See all PRAC Antibodies
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Binding Specificity
- N-Term
- Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This PRAC antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- PRAC antibody was raised in rabbit using the N terminal of PRAC as the immunogen
- Top Product
- Discover our top product PRAC Primary Antibody
-
-
- Application Notes
- Optimal conditions should be determined by the investigator.
- Comment
-
PRAC Blocking Peptide, catalog no. 33R-2130, is also available for use as a blocking control in assays to test for specificity of this PRAC antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
- Alternative Name
- PRAC (PRAC Products)
- Synonyms
- C17orf92 antibody, PRAC antibody, PRAC1 small nuclear protein antibody, PRAC1 antibody
- Background
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. Synonyms: Polyclonal PRAC antibody, Anti-PRAC antibody, prostate cancer susceptibility candidate antibody, C17orf92 antibody, MGC32520 antibody.
-